Charles N. York II, COO and CFO at Day One Biopharmaceuticals, Inc. (DAWN), sold 4,106 shares at $6.77 ($28K) on 2025-08-18, disclosed to the SEC on 2025-08-19.
Seasonal sale ($28k) by COO and CFO — this insider has traded DAWN in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2025-05-19 | $27K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $105K | — | Filing → |
| DAWN | SELL | 2024-11-19 | $34K | — | Filing → |